AAAAAA

   
Results: 1-11 |
Results: 11
STRATEGIES FOR RECRUITMENT TO A POPULATION-BASED LUNG-CANCER PREVENTION TRIAL - THE CARET EXPERIENCE WITH HEAVY SMOKERS
Authors: GOODMAN GE VALANIS B MEYSKENS FL WILLIAMS JH METCH BJ THORNQUIST MD OMENN GS
Citation: Ge. Goodman et al., STRATEGIES FOR RECRUITMENT TO A POPULATION-BASED LUNG-CANCER PREVENTION TRIAL - THE CARET EXPERIENCE WITH HEAVY SMOKERS, Cancer epidemiology, biomarkers & prevention, 7(5), 1998, pp. 405-412
DETERMINANTS OF SERUM CAROTENOIDS AND FAT-SOLUBLE VITAMINS - BASE-LINE RESULTS FROM THE SENTINEL SITE OF THE OLESTRA POSTMARKETING SURVEILLANCE STUDY
Authors: ROCK CL KRISTAL AR PATTERSON RE NEUHOUSER M NEUMARKSZTAINER D SCHREINER PJ CHESKIN L THORNQUIST MD
Citation: Cl. Rock et al., DETERMINANTS OF SERUM CAROTENOIDS AND FAT-SOLUBLE VITAMINS - BASE-LINE RESULTS FROM THE SENTINEL SITE OF THE OLESTRA POSTMARKETING SURVEILLANCE STUDY, The FASEB journal, 12(4), 1998, pp. 3160-3160
BETA-CAROTENE AND THE RISK OF LUNG-CANCER - RESPONSES
Authors: OMENN GS THORNQUIST MD
Citation: Gs. Omenn et Md. Thornquist, BETA-CAROTENE AND THE RISK OF LUNG-CANCER - RESPONSES, Journal of the National Cancer Institute, 89(6), 1997, pp. 457-458
RISK-FACTORS FOR LUNG-CANCER AND FOR INTERVENTION EFFECTS IN CARET, THE BETA-CAROTENE AND RETINOL EFFICACY TRIAL
Authors: OMENN GS GOODMAN GE THORNQUIST MD BALMES J CULLEN MR GLASS A KEOGH JP MEYSKENS FL VALANIS B WILLIAMS JH BARNHART S CHERNIACK MG BRODKIN CA HAMMAR S
Citation: Gs. Omenn et al., RISK-FACTORS FOR LUNG-CANCER AND FOR INTERVENTION EFFECTS IN CARET, THE BETA-CAROTENE AND RETINOL EFFICACY TRIAL, Journal of the National Cancer Institute, 88(21), 1996, pp. 1550-1559
CARET - THE BETA-CAROTENE AND RETINOL EFFICACY TRIAL FOR THE CHEMOPREVENTION OF LUNG-CANCER IN HIGH-RISK POPULATIONS
Authors: GOODMAN GE OMENN GS THORNQUIST MD
Citation: Ge. Goodman et al., CARET - THE BETA-CAROTENE AND RETINOL EFFICACY TRIAL FOR THE CHEMOPREVENTION OF LUNG-CANCER IN HIGH-RISK POPULATIONS, Journal of clinical oncology, 14(5), 1996, pp. 2023-2023
EFFECTS OF A COMBINATION OF BETA-CAROTENE AND VITAMIN-A ON LUNG-CANCER AND CARDIOVASCULAR-DISEASE
Authors: OMENN GS GOODMAN GE THORNQUIST MD BALMES J CULLEN MR GLASS A KEOGH JP MEYSKENS FL VALANIS B WILLIAMS JH BARNHART S HAMMAR S
Citation: Gs. Omenn et al., EFFECTS OF A COMBINATION OF BETA-CAROTENE AND VITAMIN-A ON LUNG-CANCER AND CARDIOVASCULAR-DISEASE, The New England journal of medicine, 334(18), 1996, pp. 1150-1155
THE CAROTENE AND RETINOL EFFICACY TRIAL (CARET) TO PREVENT LUNG-CANCER IN HIGH-RISK POPULATIONS - PILOT-STUDY WITH ASBESTOS-EXPOSED WORKERS
Authors: OMENN GS GOODMAN GE THORNQUIST MD ROSENSTOCK L BARNHART S GYLYSCOLWELL I METCH B LUND B
Citation: Gs. Omenn et al., THE CAROTENE AND RETINOL EFFICACY TRIAL (CARET) TO PREVENT LUNG-CANCER IN HIGH-RISK POPULATIONS - PILOT-STUDY WITH ASBESTOS-EXPOSED WORKERS, Cancer epidemiology, biomarkers & prevention, 2(4), 1993, pp. 381-387
THE CAROTENE AND RETINOL EFFICACY TRIAL (CARET) TO PREVENT LUNG-CANCER IN HIGH-RISK POPULATIONS - PILOT-STUDY WITH CIGARETTE SMOKERS
Authors: GOODMAN GE OMENN GS THORNQUIST MD LUND B METCH B GYLYSCOLWELL I
Citation: Ge. Goodman et al., THE CAROTENE AND RETINOL EFFICACY TRIAL (CARET) TO PREVENT LUNG-CANCER IN HIGH-RISK POPULATIONS - PILOT-STUDY WITH CIGARETTE SMOKERS, Cancer epidemiology, biomarkers & prevention, 2(4), 1993, pp. 389-396
STATISTICAL DESIGN AND MONITORING OF THE CAROTENE AND RETINOL EFFICACY TRIAL (CARET)
Authors: THORNQUIST MD OMENN GS GOODMAN GE GRIZZLE JE ROSENSTOCK L BARNHART S ANDERSON GL HAMMAR S BALMES J CHERNIACK M CONE J CULLEN MR GLASS A KEOGH JP MEYSKENS F VALANIS B WILLIAMS JH
Citation: Md. Thornquist et al., STATISTICAL DESIGN AND MONITORING OF THE CAROTENE AND RETINOL EFFICACY TRIAL (CARET), Controlled clinical trials, 14(4), 1993, pp. 308-324
RESEARCH COST ANALYSES TO AID IN DECISION-MAKING IN THE CONDUCT OF A LARGE PREVENTION TRIAL, CARET
Authors: THORNQUIST MD URBAN N TSENG A EDELSTEIN C LUND B OMENN GS
Citation: Md. Thornquist et al., RESEARCH COST ANALYSES TO AID IN DECISION-MAKING IN THE CONDUCT OF A LARGE PREVENTION TRIAL, CARET, Controlled clinical trials, 14(4), 1993, pp. 325-339
PROPORTIONAL HAZARDS MODEL FOR REPEATED-MEASURES WITH MONOTONIC ORDINAL RESPONSE
Authors: THORNQUIST MD
Citation: Md. Thornquist, PROPORTIONAL HAZARDS MODEL FOR REPEATED-MEASURES WITH MONOTONIC ORDINAL RESPONSE, Biometrics, 49(3), 1993, pp. 721-730
Risultati: 1-11 |